The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Peptidomimetic therapeutics: scientific approaches and opportunities
Open accessAbstract
Natural endogenously occurring peptides exhibit desirable medicinal properties, but are often limited in application by rapid proteolysis and inadequate membrane permeability. However, editing naturally occurring peptide sequences to develop peptidomimetic analogs created a promising class of therapeutics that can augment or inhibit molecular interactions. Here, we discuss a variety of chemical modifications, including L to D isomerization, cyclization, and unnatural amino acid substitution, as well as design strategies, such as attachment to cell-penetrating peptides, which are used to develop peptidomimetics. We also provide examples of approved peptidomimetics and discuss several compounds in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthesis of Proteins by Native Chemical Ligation
Dawson, P. E., Muir, T. W., Clark-Lewis, I., & Kent, S. B. H. (1994) · Science · doi:10.1126/science.7973629 · Cited by 4,131
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Conformation and Biological Activity of Cyclic Peptides
Kessler, H. (1982) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198205121 · Cited by 868
Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress: Miniperspective
Walensky, L. D., & Bird, G. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011675 · Cited by 795
Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
(1922) · PubMed · Cited by 753
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750 · cited 1×
“A comprehensive list of peptides and peptidomimetics used in the clinic was previously reviewed [9].”
BackgroundMas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
Gentilucci, L., De Marco, R., & Cerisoli, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292555 · Cited by 586
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515 · cited 1×
“Additional promising peptide delivery methods include nasal, transmucosal, sublingual, transdermal, and topical administration [49,50].”
BackgroundN‐Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions
Chatterjee, J., Rechenmacher, F., & Kessler, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201205674 · Cited by 494
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
Uhlig, T., Kyprianou, T., Martinelli, F. G., Oppici, C. A., Heiligers, D., Hills, D., Calvo, X. R., & Verhaert, P. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.05.003 · Cited by 456
Kim, D., MacConell, L., Zhuang, D., Kothare, P. A., Trautmann, M., Fineman, M., & Taylor, K. (2007) · Diabetes Care · doi:10.2337/dc06-2375 · Cited by 446
Current challenges in peptide-based drug discovery
Otvos, L., & Wade, J. D. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00062 · Cited by 363
Pancreatic Extracts in The Treatment of Diabetes Mellitus
Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R., & Fletcher, A. A. (1956) · Diabetes · doi:10.2337/diab.5.1.69 · Cited by 347
Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
Szeto, H. H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 274
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 222
Bock, J. E., Gavenonis, J., & Kritzer, J. A. (2013) · ACS Chemical Biology · doi:10.1021/cb300515u · Cited by 221
Backbone cyclization: A new method for conferring conformational constraint on peptides
Gilon, C., Halle, D., Chorev, M., Selincer, Z., & Byk, G. (1991) · Biopolymers · doi:10.1002/bip.360310619 · Cited by 208
Survase, S. A., Kagliwal, L. D., Annapure, U. S., & Singhal, R. S. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.004 · Cited by 166
Flexible Or Fixed: A Comparative Review Of Linear And Cyclic Cancer-Targeting Peptides
Roxin, Á., & Zheng, G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.75 · Cited by 166
Ziconotide: a clinical update and pharmacologic review
Pope, J. E., & Deer, T. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.784269 · Cited by 159
Gilbert, M. R., Kuhn, J., Lamborn, K. R., Lieberman, F. S., Wen, P. Y., Mehta, M. P., Cloughesy, T. F., Lassman, A. B., DeAngelis, L. M., Chang, S. M., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0650-1 · Cited by 140
Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell
Lönn, P., & Dowdy, S. F. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1046431 · Cited by 136
Madsbad, S. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.008 · Cited by 134
From somatostatin to octreotide LAR: evolution of a somatostatin analogue
Anthony, L. B., & Freda, P. U. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903328959 · Cited by 124
Library-based display technologies: where do we stand?
Galán, A., Comor, L., Horvatić, A., Kuleš, J., Guillemin, N., Mrljak, V., & Bhide, M. R. (2016) · Molecular BioSystems · doi:10.1039/c6mb00219f · Cited by 121
Stapled peptide design: principles and roles of computation
Tan, Y. S., Lane, D. P., & Verma, C. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.012 · Cited by 116
A Genetically Encoded aza-Michael Acceptor for Covalent Cross-Linking of Protein–Receptor Complexes
Furman, J. L., Kang, M., Choi, S., Cao, Y. J., Wold, E. D., Sun, S. B., Smider, V. V., Schultz, P. G., & Kim, C. H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502851h · Cited by 112
Antibody conjugates with unnatural amino acids.
Hallam, T., Wold, E. D., Wahl, A., & Smider, V. V. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00082 · Cited by 112
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Hamed, K. A., González-Ruiz, A., & Seaton, A. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s99046 · Cited by 102
Amiram, M., Luginbuhl, K. M., Li, X., Feinglos, M. N., & Chilkoti, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214518110 · Cited by 99
Ruiz‐Gómez, G., Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2010) · Chemical Reviews · doi:10.1021/cr900344w · Cited by 99
Intracellullar peptides as putative natural regulators of protein interactions
Ferro, E. S., Hyslop, S., & de Camargo, A. C. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02757.x · Cited by 97
Whitby, L. R., Ando, Y., Setola, V., Vogt, P. K., Roth, B. L., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201878v · Cited by 84
Khoury, G. A., Smadbeck, J. B., Tamamis, P., Vandris, A. C., Kieslich, C. A., & Floudas, C. A. (2014) · ACS Synthetic Biology · doi:10.1021/sb400168u · Cited by 73
Peptides as ‘Drugs’: The Journey so Far
Sachdeva, S. (2016) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-016-9534-8 · Cited by 72
Li, J., Chen, X., Xiao, W., Ma, W., Li, T., Huang, J., Liu, X., Liang, X., Tang, S., & Luo, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.122 · Cited by 71
Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids
Grünewald, J., Hunt, G. S., Dong, L., Niessen, F., Wen, B. G., Tsao, M., Perera, R., Kang, M., Laffitte, B. A., Azarian, S. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900507106 · Cited by 67
New Opportunities in Vasopressin and Oxytocin Research: A Perspective from the Amygdala
Stoop, R., Hegoburu, C., & van den Burg, E. H. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033904 · Cited by 65
Improvement of drug-like properties of peptides: the somatostatin paradigm
Ovadia, O., Greenberg, S., Laufer, B., Gilon, C., Hoffman, A., & Kessler, H. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.493935 · Cited by 65
Linaclotide: A novel agent for chronic constipation and irritable bowel syndrome
Love, B. L., Johnson, A., & Smith, L. S. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130575 · Cited by 60
Role of Angiotensin and Its Inhibition in Hypertension, Ischemic Heart Disease, and Heart Failure
Gavras, H. P., & Brunner, H. R. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.342 · Cited by 60
New medical therapies for heart failure
von Lueder, T. G., & Krum, H. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.137 · Cited by 55
HAE therapies: past present and future
Zuraw, B. L. (2010) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-6-23 · Cited by 54
Khasraw, M., Lee, A., McCowatt, S., Kerestes, Z., Buyse, M. E., Back, M., Kichenadasse, G., Ackland, S. P., & Wheeler, H. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2094-0 · Cited by 54
Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery
Gruber, C. W., Koehbach, J., & Muttenthaler, M. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.108 · Cited by 49
Chen, M., Liu, B., Gao, Q., Zhuo, Y., & Ge, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7524 · Cited by 43
Bork, K., Yasothan, U., & Kirkpatrick, P. N. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2694 · Cited by 43
Therapies for diabetes: pramlintide and exenatide.
Jones, M. C. (2007) · PubMed · Cited by 35
Becker, A., von Richter, O., Kovar, A., Scheible, H., van Lier, J. J., & Johne, A. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.482 · Cited by 23
Cited by
Electrochemical strategies for C–H functionalization and C–N bond formation
Kärkäs, M. D. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00619e · Cited by 1,003
Factors affecting the physical stability (aggregation) of peptide therapeutics
Zapadka, K. L., Becher, F. J., Gomes dos Santos, A. L., & Jackson, S. E. (2017) · Interface Focus · doi:10.1098/rsfs.2017.0030 · Cited by 401
Peptidomimetic toolbox for drug discovery
Lenci, E., & Trabocchi, A. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00102c · Cited by 326
Chen, S., Lin, T., Basu, R., Ritchey, J., Wang, S., Luo, Y., Li, X., Pei, D., Kara, L. B., & Cheng, X. (2024) · Nature Communications · doi:10.1038/s41467-024-45766-2 · Cited by 324
Dietrich, L., Rathmer, B., Ewan, K., Bange, T., Heinrichs, S., Dale, T. C., Schade, D., & Grossmann, T. N. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.06.013 · Cited by 126
Metadata
- Authors
- Qvit, N., Rubin, S. J. S., Urban, T. J., Mochly-Rosen, D., & Gross, E. R.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 22
- Issue
- 2
- Pages
- 454-462
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2556148213
- Cited by
- 273
- References
- 55
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.